1034 Results

People

  1. Vickers
    Vickers
  2. Lilja
    Lilja
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Reuter
    Reuter
  9. Slovin
    Slovin
  10. Morris
    Morris

Groups

  1. Surgery (448)
  2. Urology (445)
  3. Population Sciences Research Program (323)
  4. Sloan Kettering Institute Faculty (281)
  5. Molecular Pharmacology and Chemistry Program Faculty (277)
  6. Epidemiology and Biostatistics (276)
  7. Department of Medicine (255)
  8. Solid Tumor Oncology Division (244)
  9. Genitourinary Oncology Service (229)
  10. Health Outcomes Research Group (208)
  1. "prostate specific antigen"
Formats
  1. Journal Article (967)
  2. Editorial (18)
  3. Review (17)
  4. Conference Paper (14)
  5. Correspondence (8)
  6. Guidelines (6)
  7. Research Letter (3)
  8. Miscellaneous (1)
Groups
  1. Surgery (448)
  2. Urology (445)
  3. Population Sciences Research Program (323)
  4. Sloan Kettering Institute Faculty (281)
  5. Molecular Pharmacology and Chemistry Program Faculty (277)
  6. Epidemiology and Biostatistics (276)

More Groups

People
  1. Peter Scardino (194)
  2. Andrew Vickers (164)
  3. Hans Lilja (162)
  4. Howard Scher (156)
  5. James Eastham (138)
  6. Michael Zelefsky (93)

More People

Years
  1. 2025 (16)
  2. 2024 (45)
  3. 2023 (39)
  4. 2022 (33)
  5. 2021 (10)
  6. 2020 (22)

More Years

Publications
  1. European Urology (107)
  2. Journal of Urology (86)
  3. Urology (67)
  4. Journal of Clinical Oncology (63)
  5. Cancer (47)
  6. Clinical Cancer Research (47)

More Publications

Publishers
  1. Elsevier Science, Inc. (294)
  2. Elsevier Inc. (115)
  3. Wiley Blackwell (95)
  4. American Association for Cancer Research (71)
  5. American Society of Clinical Oncology (66)
  6. Nature Publishing Group (49)

More Publishers

Results (1034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between new unconfirmed bone lesions and outcomes in men with metastatic castration-resistant prostate cancer treated with enzalutamide: Secondary analysis of the PREVAIL and AFFIRM randomized clinical trials
    Journal Article

    Armstrong, A. J.; Al-Adhami, M.; Lin, P.; Parli, T.; Sugg, J.; Steinberg, J.; Tombal, B.; Sternberg, C. N.; De Bono, J.; Scher, H. I.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance
    Journal Article

    Chesnut, G. T.; Vertosick, E. A.; Benfante, N.; Sjoberg, D. D.; Fainberg, J.; Lee, T.; Eastham, J.; Laudone, V.; Scardino, P.; Touijer, K.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
    Journal Article

    Assel, M. J.; Ulmert, H. D.; Karnes, R. J.; Boorjian, S. A.; Hillman, D. W.; Vickers, A. J.; Klee, G. G.; Lilja, H.
    Prostate (2020)

    Fulltext@MSK | Save
  • Overview of established and emerging immunohistochemical biomarkers and their role in correlative studies in MRI
    Review

    Alvi, E.; Gupta, R.; Borok, R. Z.; Escobar-Hoyos, L.; Shroyer, K. R.
    Journal of Magnetic Resonance Imaging (2020)

    Fulltext@MSK | Save
  • Clinical utility of the nuclear-localized AR-V7 biomarker in circulating tumor cells in improving physician treatment choice in castration-resistant prostate cancer
    Journal Article

    Graf, R. P.; Hullings, M.; Barnett, E. S.; Carbone, E.; Dittamore, R.; Scher, H. I.
    European Urology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
    Journal Article

    Higano, C. S.; Armstrong, A. J.; Sartor, A. O.; Vogelzang, N. J.; Kantoff, P. W.; McLeod, D. G.; Pieczonka, C. M.; Penson, D. F.; Shore, N. D.; Vacirca, J.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Guideline of guidelines: Testosterone therapy for testosterone deficiency
    Review

    Salter, C. A.; Mulhall, J. P.
    BJU International (2019)

    Fulltext@MSK | Save
  • Interim results from the IMPACT study: Evidence for prostate-specific antigen screening in BRCA2 mutation carriers
    Journal Article

    Page, E. C.; Bancroft, E. K.; Brook, M. N.; Assel, M.; Al Battat, M. H.; Thomas, S.; Taylor, N.; Chamberlain, A.; Pope, J.; Raghallaigh, H. N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
    Journal Article

    Berney, D. M.; Beltran, L.; Sandu, H.; Soosay, G.; Møller, H.; Scardino, P.; Murphy, J.; Ahmad, A.; Cuzick, J.; on behalf of the Transatlantic Prostate Group
    Histopathology (2019)

    Fulltext@MSK | Save
  • Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
    Journal Article

    Cavalcanti Viana, P. C.; Horvat, N.; dos Santos Júnior, V. R.; Lima, T. C.; Romão, D. S.; Cerri, L. M. O.; de Castro, M. G.; Vargas, H. A.; Miranda, J. A.; Leite, C. C.; more...
    International Brazilian Journal of Urology (2019)

    Fulltext@MSK | Save